You are here: Home > Newsroom > Detail > BirgiMefar Group

Content

Raiffeisen Investment has successfully completed the sale of majority stake in BirgiMefar Group to two PE houses; NBGI and Ethemba Capital.

7 July 2011

Raiffeisen Investment advised the sellers of BirgiMefar Group, a leading Turkish pharmaceuticals contract manufacturing and services group, on the sale of its majority stake to two leading private equity houses, Ethemba Capital and NBGI Private Equity.

Founded in 1963 by Adnan Birgi and based in Istanbul, Turkey, BirgiMefar Group is one of the oldest players of the Turkish Pharmaceutical Industry focusing on contract manufacturing of small and medium parenteral solutions in ampoules, vials, BFS and syringes.

NBGI PE is one of the leading private equity and venture capital investment firms of Europe managing EUR 900m across a number of different funds.
Ethemba Capital is a UK based private equity firm founded in 2006, specialized in emerging markets and managing funds over EUR 500m.

The transaction was closed on June 30, 2011.

Raiffeisen Investment acted as the exclusive financial advisor of BirgiMefar Group.


Servicebox